Market Minds Advisory
Airway Management Devices Market

Airway Management Devices Market: The Video Laryngoscopy Shift and the First-Pass Success Standard

Difficult airway guidelines increasingly recommending video laryngoscopy as first-line are pulling procurement away from direct laryngoscopes, forcing legacy device manufacturers to build video capability or cede share to imaging-native specialists.

Lead Analyst

Alice Ballenger

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$3.9BMarket Size 2025
2036 FORECAST VALUE$7.7BBase Case , 2026 to 2036
CAGR 2026 TO 20366.4 %Bull 7.5% / Bear 5.1%
INCREMENTAL OPPORTUNITY$3.6BNet 10- year value creation
EXPANSION MULTIPLE1.86x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory

Airway management device demand is shifting from direct laryngoscopy toward video-enabled devices as clinical guidelines increasingly recommend video laryngoscopy as a first-line intubation tool, converting a category once defined by simple mechanical blades into one where imaging quality and first-pass success data drive purchasing decisions across nearly every anesthesia department.
Video laryngoscopes are growing fastest, at roughly ten and a half percent annually, as anesthesiology and emergency medicine departments adopt video-guided intubation to improve first-pass success rates and reduce complications associated with repeated intubation attempts. East Asia holds the largest single regional share on the strength of China's extensive surgical and anesthesia procedure volume, while India's rapidly expanding surgical infrastructure drives the fastest single-country growth.
Competitive intensity concentrates around imaging quality and clinical evidence supporting first-pass success rather than base device pricing alone, since hospital procurement committees increasingly require documented outcomes data before standardizing on a video laryngoscopy platform across their facility. Established airway device manufacturers are investing in video technology to defend legacy laryngoscope positions, while imaging-native entrants compete for hospital system contracts where video capability, not blade design, ultimately determines the winning bid.
Market Definition
The airway management devices market covers devices used to establish and maintain a patent airway during anesthesia, emergency medicine, and critical care, including endotracheal tubes, supraglottic airway devices, laryngoscopes, tracheostomy tubes, and airway exchange catheters. It excludes mechanical ventilators sold as standalone respiratory support equipment and excludes general anesthesia delivery systems sold independently of airway devices.
Base Year Value
$3.9B in 2025 (MMA Primary Research Dataset, August 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
6.4% base case. Bull 7.5%. Bear 5.1%.
Fastest Growth Segment
Video Laryngoscopes: 10.8% CAGR
Fastest Growth Country
India: 9.5% CAGR
Fastest Growth Region
South Asia and Pacific: 8.6% CAGR
Largest Region
East Asia: 30% of 2025 global value
Market Leaders
Medtronic plc, Teleflex Incorporated, Ambu A/S, Vyaire Medical Inc., Intersurgical Ltd. Source: MMA Analysis based on company annual reports and investor filings.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Airway Management Devices Market Forecast Scenarios

airway-management-devices-market-size-forecast-scenario-1787297532507
Airway management device demand fell in 2020 as elective surgical procedures paused during pandemic disruption, then recovered through 2022 as surgical volume normalized and emergency intubation demand rose during acute pandemic care surges. Growth continued through 2024 as video laryngoscopy adoption broadened beyond its original difficult-airway niche use. The market grew at a historical rate of roughly 5.7% annually across the 2020 to 2025 period, gaining momentum as adoption widened.
The base case assumes growth driven by three mechanisms: clinical guidelines increasingly recommending video laryngoscopy as a first-line rather than rescue intubation tool, expanding the addressable device category beyond difficult-airway cases; growing surgical procedure volume across Asia requiring proportional airway device consumption; and rising emergency medical services adoption of supraglottic airway devices for prehospital airway management. Replacement demand from routine single-use device consumption adds a steady secondary layer independent of new procedure growth.
The bull case rests on faster-than-expected video laryngoscopy guideline adoption pulling forward device replacement across thousands of hospital anesthesia departments simultaneously. The bear case centers on a hospital capital spending slowdown, mirroring past healthcare budget tightening cycles, that would defer video laryngoscope fleet upgrades and stretch replacement cycles while routine disposable device consumption remains comparatively stable.

Imaging Capability Redefines a Mechanical Device Category

Airway management devices sit at a genuinely safety-critical point in anesthesia and emergency care, where the seconds required to secure an airway can directly determine patient outcomes in both routine and difficult intubation cases. Video laryngoscopy has moved from a specialized rescue tool into a first-line standard many anesthesia departments now apply broadly, converting device selection into a clinical quality metric hospitals actively track.
MARKET CONCENTRATION52% (CR5)Moderately concentrated base spans global device manufacturers broadly
AVERAGE DEVICE COST$8-$12,500Price spans disposable airways to full video laryngoscopy systems
TOP PRODUCING COUNTRYChina, 21% shareLargest single manufacturing base tied to surgical procedure scale
CAPACITY UTILIZATION74%Manufacturing lines run moderately below full theoretical capacity
FIRST-PASS SUCCESS RATE89% with videoDocumented success rate compared with direct laryngoscopy baseline
INPUT COST SHARE36% of COGSOptical components, medical-grade plastics, and electronics dominate cost
Demand concentrates where surgical procedure volume and clinical guideline adoption intersect most directly. East Asia and North America generate the largest absolute investment given extensive surgical infrastructure and early video laryngoscopy guideline adoption, while South Asia and Pacific combines rapid surgical volume growth with expanding hospital infrastructure investment. Emergency medical services and prehospital care represent a genuinely distinct demand channel from hospital-based anesthesia procurement.
Over the next decade, imaging quality and documented clinical outcomes data increasingly determine competitive position more than blade design or base device pricing alone. Suppliers able to demonstrate superior first-pass success rates and reduced complication data will capture share from legacy direct laryngoscopy manufacturers in a market where hospital procurement committees increasingly treat airway device selection as a patient safety decision rather than a routine supply purchase.
"A direct laryngoscope used to be the default because it was cheap and everyone knew how to use one. Now a hospital risk management committee wants to see the first-pass success data before anyone signs off on the purchase order."
Director, Anesthesia and Critical Care Devices Practice · MMA Anesthesia and Cri

Market Trends

Video Laryngoscopy Becomes a First-Line Clinical Standard

Clinical practice guidelines from major anesthesiology societies increasingly recommend video laryngoscopy as a first-line intubation tool rather than reserving it for anticipated difficult airways, reflecting accumulating evidence that video guidance improves first-pass success and reduces complications across intubation cases. This is pushing hospital anesthesia departments to standardize video laryngoscopy across their entire device fleet rather than maintaining video units only for difficult-airway carts. Manufacturers with proven video technology and supporting clinical evidence are capturing disproportionate share of this fleet-wide standardization, while manufacturers offering only direct laryngoscopy face a genuine product line transition some address through acquisition rather than organic development.
Market Impact: Adds surgical volume-linked demand worth $310M

Emergency Medical Services Expand Supraglottic Airway Adoption

Emergency medical services protocols across major markets increasingly favor supraglottic airway devices over endotracheal intubation for prehospital airway management, reflecting evidence that supraglottic devices can be placed faster and with fewer complications by paramedics operating in less controlled field conditions than a hospital operating room. Each EMS system adopting updated protocols represents a substantial, recurring device procurement decision, since prehospital agencies typically standardize device selection across their entire fleet of ambulances and field personnel. Manufacturers with established EMS distribution relationships and proven field performance data are capturing disproportionate share of this expanding demand relative to competitors focused on hospital applications.
Market Impact: Standardizes carts across 12,000+ facilities

Market Opportunities and Growth Drivers

Expanding Surgical Volume Across Asian Healthcare Systems

Growing surgical procedure volume across China, India, and other expanding Asian healthcare systems is driving proportional demand for airway management devices, as each surgical procedure under general anesthesia requires a full set of airway devices independent of the specific procedure being performed. Each new hospital operating room represents a recurring device consumption relationship, since disposable airway devices require continuous replenishment tied directly to surgical case volume rather than a one-time capital purchase. Manufacturers with established distribution relationships across expanding Asian hospital networks are capturing disproportionate share of this volume-driven demand relative to competitors serving primarily mature, slower-growing surgical markets.
Market Impact: Delays conversion at 30% of hospitals

Difficult Airway Guidelines Drive Device Standardization

Updated difficult airway management guidelines from major anesthesiology and emergency medicine societies are driving hospital standardization around comprehensive difficult airway carts equipped with video laryngoscopy, supraglottic rescue devices, and airway exchange catheters, converting what was once inconsistent department-by-department equipment stocking into a more uniform, guideline-driven procurement standard. Each hospital implementing updated difficult airway protocols typically purchases equipment across its entire facility rather than a single department, creating a discrete, substantial procurement event. Manufacturers offering comprehensive difficult airway management product lines are capturing disproportionate share of this standardization-driven demand relative to competitors offering only individual device categories.
Market Impact: Extends review 4 to 8 months

Market Restraints and Challenges

Capital Cost Delays Video Laryngoscope Fleet Conversion

Full video laryngoscopy systems cost between $2,500 and $12,500 per unit depending on configuration, a substantial capital commitment when multiplied across a hospital's entire anesthesia fleet, causing many smaller hospitals to delay comprehensive conversion even as guidelines increasingly favor video-first protocols. The root cause is that fleet conversion competes against other capital priorities within constrained hospital budgets, particularly at smaller hospitals lacking the purchasing scale of large medical centers. This delays equipment access at facilities that may most benefit from improved success rates. Equipment lessors and vendor financing are emerging as a mitigation path, spreading the outlay over multi-year terms.
Market Impact: Lifts video laryngoscope share toward 34%

Single-Use Device Regulation Increases Compliance Complexity

Tightening regulatory scrutiny of single-use medical device reprocessing and disposal practices is increasing compliance complexity for airway device manufacturers and hospital purchasing departments, particularly as environmental sustainability concerns create pressure to consider reusable alternatives even as infection control standards continue favoring single-use devices. The root cause is that infection control and environmental sustainability priorities can genuinely conflict for airway devices that contact mucosal surfaces during use, creating a difficult tradeoff hospitals must navigate. This complicates procurement decision-making across the category. Manufacturers are responding by developing reusable device designs with improved sterilization validation to address both concerns simultaneously.
Market Impact: Adds EMS-linked demand worth $185M
3 additional market trends, 4 additional growth drivers, and 2 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

MMA segments the airway management devices market by device type, the classification that most directly determines clinical application, capital versus disposable purchasing model, and regulatory pathway for hospitals and EMS systems evaluating equipment investment across anesthesia, emergency, and critical care applications, rather than an end-use split that obscures genuine clinical and commercial distinctions across settings.
airway-management-devices-market-market-share-analysis-1787297533046

Video Laryngoscopes

Video laryngoscopes are growing fastest, at roughly 10.8% annually, as anesthesiology and emergency medicine departments adopt video-guided intubation to improve first-pass success rates and reduce complications associated with repeated intubation attempts. Adoption concentrates among hospital systems standardizing video laryngoscopy fleet-wide rather than reserving video units for anticipated difficult-airway cases alone, reflecting the broader clinical guideline shift toward video-first protocols. Unit prices run considerably higher than direct laryngoscopes, reflecting both the imaging hardware involved and the clinical evidence generation most manufacturers now invest in to support first-pass success claims. Manufacturers with proven imaging quality and documented outcomes data are capturing disproportionate share of new hospital fleet standardization decisions, positioning video laryngoscopy as the default rather than a premium option.
CAGR 10.8%

Supraglottic Airway Devices

Supraglottic airway devices are growing at roughly 8.5% annually, driven by expanding use across both hospital anesthesia and emergency medical services applications where these devices offer faster placement and fewer complications than endotracheal intubation for many procedure types and field conditions. Demand concentrates among ambulatory surgery centers favoring supraglottic devices for shorter procedures and EMS systems adopting updated prehospital airway management protocols that favor these devices for field use. This segment benefits from a broader clinical shift toward less invasive airway management wherever clinically appropriate, reducing reliance on endotracheal intubation for cases that do not specifically require it. Manufacturers with proven device designs across multiple size ranges and clinical applications are capturing disproportionate share of this expanding demand pool.
CAGR 8.5%
Full segment breakdown across 6 segments available in the complete report.

Regional Architecture and Country Demand Map

East Asia holds the largest regional share on the strength of China's extensive surgical and anesthesia procedure volume, while South Asia and Pacific grows fastest as surgical infrastructure expands rapidly across the region. North America contributes substantial demand tied to its early video laryngoscopy adoption and clinical guidelines.

North America

North America generates substantial airway management device demand anchored by the United States' early video laryngoscopy guideline adoption and its position as home to several leading device manufacturers with deep clinical evidence generation capability across academic medical centers nationwide. Emergency medical services protocol updates favoring supraglottic airway devices are accelerating demand faster here than in most other regions, given the concentration of well-funded EMS systems actively updating field protocols. Canada's healthcare system contributes steady secondary demand concentrated in similar anesthesia and emergency medicine applications. Mexico's growing surgical infrastructure, supported by expanding private hospital investment, adds incremental demand for standard airway devices rather than the most advanced video laryngoscopy systems currently concentrated in the United States.
Share: 26% | CAGR: 7.2% (2026 to 2036)

Western Europe

Western Europe's demand centers on Germany, the UK, and France, where established anesthesia societies and progressive difficult airway management guidelines sustain demand for both video laryngoscopy and comprehensive difficult airway cart standardization across the region's hospital infrastructure. The region grows the slowest of the seven as its hospital equipment base is already comparatively mature, limiting the pace of new adoption relative to faster-expanding Asian surgical markets currently under construction. German and Danish manufacturers, several of whom rank among the market's global technical leaders, maintain deep relationships with anesthesia departments and EMS systems across the continent. Growing environmental sustainability pressure is accelerating interest in reusable device alternatives faster here than in most other global regions.
Share: 21% | CAGR: 5.0% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
airway-management-devices-market-country-cagr-analysis-1787297533593

Capturing Value Beyond the Single Device Sale

Base disposable airway device pricing faces steady downward pressure from regional Chinese and Indian manufacturers competing aggressively on standard device categories. Suppliers that build recurring revenue through video system placement, clinical evidence programs, and comprehensive difficult airway cart contracts capture considerably better lifetime value than those competing purely on unit device pricing across their broader account portfolio.

Placing Video Laryngoscopy Systems With Disposable Blade Contracts

Manufacturers placing video laryngoscopy handle systems at reduced or no upfront cost in exchange for exclusive disposable blade supply agreements capture recurring revenue worth an estimated 3 to 5 times the initial handle placement value over the equipment's multi-year service life, since each intubation procedure consumes a disposable blade component tied specifically to that manufacturer's proprietary handle system. This placement model, similar to razor-and-blade commercial strategies used in other medical device categories, creates durable customer dependency that extends the commercial relationship well beyond the initial equipment placement into years of recurring consumable purchases.
Market Impact: Captures 3 to 5x more recurring blade revenue

Building Clinical Evidence Generation Programs Broadly

Manufacturers investing in clinical evidence generation partnerships with academic medical centers, worth an estimated $310 million in addressable surgical volume-linked demand, capture disproportionate share of hospital fleet standardization decisions as documented first-pass success and complication reduction data accumulates across expanding clinical use cases and hospital settings nationwide over multiple years. This evidence generation requires sustained research investment but positions manufacturers to win competitive hospital procurement decisions where clinical outcomes data increasingly outweighs base device pricing considerations in committee evaluation criteria used across most major health systems and their affiliated networks.
Market Impact: Captures a growing $310M evidence demand pool now

Expanding Comprehensive Difficult Airway Cart Contracts

Manufacturers offering comprehensive difficult airway cart packages spanning video laryngoscopy, supraglottic rescue devices, and airway exchange catheters, worth an estimated $2 to $3 million per major hospital system contract, capture larger, more durable hospital relationships than individual device category sales, since hospitals increasingly prefer standardizing an entire difficult airway protocol with a single manufacturer rather than sourcing each device category separately. This bundled contract approach simplifies hospital staff training and inventory management while creating a broader, more defensible account relationship that single-category competitors cannot easily displace once established across a facility network.
Market Impact: Wins cart contracts worth 2 to 3x more

Growing EMS and Prehospital Distribution Relationships

Manufacturers building dedicated EMS and prehospital care distribution relationships are capturing disproportionate share of a demand pool worth an estimated $185 million tied to expanding supraglottic airway adoption in field protocols, a channel requiring different distribution infrastructure and field-specific product validation than hospital-focused sales entirely and considerably. This channel investment requires meaningful sales infrastructure but positions manufacturers to capture recurring device relationships across an EMS system's entire fleet of ambulances and field personnel as protocols continue evolving toward supraglottic-first approaches across the country and increasingly across international EMS systems as well.
Market Impact: Captures a growing $185M EMS demand pool now

Who Controls the Margin Pool

The airway management devices market is moderately concentrated, with a CR5 of roughly 52%. Medtronic and Teleflex lead a group of diversified global device manufacturers with a meaningful gap over the next tier of specialized video laryngoscopy and regional device manufacturers competing across multiple device categories and clinical settings simultaneously across their expanding global operations today.
Competitive activity concentrates on three fronts: video laryngoscopy technology and clinical evidence that deepens hospital relationships beyond device pricing, comprehensive difficult airway cart bundling that captures larger contracts, and EMS distribution expansion tied to expanding prehospital supraglottic airway adoption. Established suppliers defend positions through decades of clinical relationships and regulatory clearance history that smaller regional manufacturers cannot easily replicate quickly or affordably.

Emerging pressure comes from video laryngoscopy specialists building genuine imaging and outcomes data advantages that established mechanical device manufacturers are racing to match through acquisition rather than organic development across their broader portfolios. Rankings could shift meaningfully if a video specialist successfully wins a major hospital system's enterprise-wide fleet standardization contract, demonstrating credible multi-facility scale that has historically been the primary advantage of established diversified device manufacturers.
airway-management-devices-market-company-positioning-matrix-1787297534123

Competitive Moat and Risk Dimensions

MEDTRONIC PLC

Moat: Broad Multi-Category Device Portfolio

Medtronic's device portfolio spans endotracheal tubes, supraglottic airways, and video laryngoscopy simultaneously, allowing it to serve hospital anesthesia departments across the full spectrum of airway management requirements rather than being confined to a single device category that smaller, more specialized competitors typically offer their more limited customer base.
MEDTRONIC PLC

Risk: Exposure to Legacy Device Categories

A meaningful share of Medtronic's airway device revenue remains tied to traditional endotracheal tube and direct laryngoscopy categories facing gradual displacement by video-enabled alternatives, requiring sustained investment in video technology to offset this comparatively slower-growing legacy revenue segment across its broader business and revenue mix over time.
TELEFLEX INCORPORATED

Moat: Deep Difficult Airway Cart Relationships

Teleflex's established difficult airway cart bundling relationships with hospital anesthesia departments give it recurring, multi-year contract relationships that newer entrants without comparable comprehensive product line breadth and hospital trust cannot easily replicate, particularly for complex difficult airway management protocol standardization across large multi-facility hospital networks.
TELEFLEX INCORPORATED

Risk: Limited EMS Channel Presence

Teleflex's commercial focus remains more concentrated in hospital-based anesthesia applications relative to its position in the faster-growing EMS and prehospital care markets, where dedicated distribution relationships increasingly determine which manufacturer captures expanding supraglottic airway adoption in field protocols across ambulance fleets nationwide and further beyond.

Players Tracked

Prominent Players

Medtronic plc
Teleflex Incorporated
Ambu A/S
Vyaire Medical Inc.
Intersurgical Ltd.

Other Key Players

Smiths Medical
GE Healthcare
Verathon Inc
Karl Storz SE and Co KG
Flexicare Medical Ltd
SunMed
Well Lead Medical Co Ltd
Armstrong Medical Ltd
VBM Medizintechnik GmbH
Mercury Medical
Hsiner Co Ltd
Zhejiang Kangbao Medical Devices
Pacific Hospital Supply
Truphatek International
ICU Medical Inc

Recent Developments

FEBRUARY 2025

Medtronic Launches Expanded Video Laryngoscopy Product Line

Medtronic plc launched an expanded video laryngoscopy product line with improved imaging resolution and a broader range of blade sizes, aimed at hospital anesthesia departments seeking to standardize video-first intubation protocols across both routine and difficult airway cases according to recently updated clinical guidelines from major societies.
Signal: Signals that established device manufacturers are now proactively prioritizing video capability across their full product portfolio.
JUNE 2025

Ambu Signs Major Hospital System Fleet Standardization Contract

Ambu A/S signed a fleet standardization agreement with a major hospital system to deploy its video laryngoscopy systems across all anesthesia departments network-wide, its largest enterprise contract to date, demonstrating growing hospital preference for single-vendor video laryngoscopy standardization over mixed-vendor equipment fleets across multiple departments.
Signal: Signals that hospital systems increasingly favor single-vendor standardization over maintaining multiple different, directly competing equipment platforms.
OCTOBER 2025

Verathon Expands EMS Distribution Partnership Network

Verathon Inc. expanded its distribution partnership network serving emergency medical services agencies, aimed at capturing growing demand from EMS systems updating prehospital airway management protocols to favor video-guided intubation and supraglottic airway devices over traditional field intubation techniques used previously by paramedics in less controlled settings.
Signal: Signals that manufacturers are now actively building dedicated EMS channel capability distinct from hospital-focused sales infrastructure.

Optical Components, Medical Plastics, and Electronics

Optical components and imaging sensors used in video laryngoscopy systems account for roughly 20 to 25% of manufacturing cost, sourced from a concentrated group of specialized precision optics manufacturers primarily based in Japan, Germany, and the United States. Medical-grade plastics and electronic components contribute a further 14 to 18%, exposing manufacturers to precision electronics supply chains alongside traditional medical device material markets.
The 2021 to 2022 global semiconductor shortage delayed imaging sensor and electronic component deliveries for several video laryngoscopy manufacturers, extending equipment lead times from a typical eight to ten weeks to over six months in some cases, according to component sourcing disclosures in Medtronic's 2022 annual report. The disruption prompted several manufacturers to qualify secondary electronics suppliers and redesign imaging systems around more broadly available component families.

Smaller regional manufacturers without long-term component supply agreements face greater cost exposure than larger diversified players like Medtronic and Teleflex, who negotiate volume-based contracts directly with optics and electronics suppliers. Manufacturers focused on video laryngoscopy face additional exposure to imaging sensor pricing volatility, a supply chain risk that manufacturers of simpler disposable airway devices sourcing more standardized materials do not share to the same degree.
airway-management-devices-market-cost-volatility-analysis-1787297534329

Qualifying Secondary Optical Component Suppliers

Manufacturers are increasingly qualifying secondary optical sensor and imaging component suppliers across different regions to reduce exposure to any single supplier's capacity constraints during periods of tight component supply and elevated global demand across multiple competing electronics and medical device sectors worldwide, all simultaneously drawing on the same limited pool of qualified suppliers globally.

Standardizing Imaging Architectures for Component Flexibility

Several manufacturers have redesigned video laryngoscopy imaging architectures to accommodate a broader range of interchangeable optical and electronic components, reducing dependence on any single specific part number and shortening the qualification cycle for alternate suppliers during future component supply disruptions across their broader product lineup and geographic manufacturing footprint spanning multiple continents and regulatory jurisdictions.

Building Strategic Component Inventory Reserves

Larger manufacturers have expanded safety stock of critical optical and electronic components to buffer against future supply disruption, absorbing additional working capital cost in exchange for more predictable production scheduling and customer delivery commitments across periods of elevated market volatility and rising geopolitical uncertainty affecting global component supply chains across multiple key producing regions.

Portfolio Architecture for Margin Defence

The market splits into three tiers running from commodity disposable airway devices to premium video laryngoscopy systems bundled with clinical evidence and comprehensive cart contracts. Margin concentrates heavily at the top: video laryngoscopy systems paired with disposable blade contracts earn gross margins 15 to 22 percentage points above commodity disposable devices, reflecting both imaging technology cost and the recurring consumable revenue layered on top of the initial equipment placement

Volume and premium tiers pull manufacturers in different strategic directions simultaneously across the industry. Regional Chinese and Indian manufacturers are pushing aggressively into standard disposable device categories, compressing margin in segments where established Western manufacturers historically earned steady returns, forcing incumbents to defend premium video laryngoscopy and cart-bundled segments more aggressively through clinical differentiation rather than device pricing alone.

High-value margin pools concentrate among suppliers serving large hospital systems through combined equipment placement, disposable consumable, and clinical evidence relationships, since these accounts generate recurring revenue across multiple device categories and facility expansions simultaneously, far exceeding the value of a single device transaction and remaining the primary target of every major manufacturer's account and growth strategy today.

Volume / Commodity-Adjacent Tier

Standard disposable endotracheal tubes and basic airways sold primarily into price-sensitive markets, competing on price against a fragmented global manufacturer base with thin margins reflecting commoditized devices and limited differentiation.
Gross Margin: 16-22%

Premium / Certified Tier

Mid-tier supraglottic devices and standard video laryngoscopy systems sold with technical support into growing hospital and EMS markets, capturing better margin through demonstrated clinical performance and reliability across hospital and prehospital settings alike.
Gross Margin: 26-33%

Sustainability / Regulatory / Next-Generation Tier

Premium video laryngoscopy platforms bundled with disposable blade contracts and comprehensive difficult airway cart standardization, commanding the highest margin as clinical evidence becomes a baseline hospital procurement requirement across the entire industry.
Gross Margin: 36-44%
airway-management-devices-market-portfolio-architecture-1787297534863

High-value Sub-segments and Strategic Watch-out

Video Laryngoscopy Platforms With Disposable Blade Contracts

Bundled equipment placement and consumable supply agreements generating recurring revenue through razor-and-blade style commercial relationships, growing fastest as hospital fleet standardization makes single-vendor video laryngoscopy adoption a contractual condition across expanding anesthesia department networks nationwide and across multiple facility types, hospital systems, and geographic markets.
Gross Margin: 38-44%

Comprehensive Difficult Airway Cart Standardization Contracts

Multi-device bundled contracts spanning video laryngoscopy, supraglottic rescue devices, and airway exchange catheters, expanding steadily as hospitals increasingly standardize entire difficult airway protocols with a single manufacturer rather than sourcing individual device categories separately across multiple departments, facility locations, and repeated annual procurement cycles nationwide.
Gross Margin: 32-38%

Standard Disposable Airway and Endotracheal Devices

The largest unit volume segment, serving hospital and surgical facilities globally that need proven airway management without the highest tier's full video and evidence cost, forming the steady revenue backbone of most manufacturers' current order books and multi-year service, supply, and technical support contracts nationwide.
Gross Margin: 18-24%

Legacy Direct Laryngoscopes Facing Displacement

Older direct laryngoscopy devices facing gradual displacement by video-enabled alternatives across both routine and difficult airway applications, a segment strategic watchers should track as guideline-driven adoption shifts faster than some manufacturers' transition plans currently anticipate or have adequately planned for across their long-term capital budgets.
Gross Margin: 14-20%

From Sale to Fleet Relationship

Airway management device demand is shifting from a one-time device sale toward an ongoing fleet standardization relationship as video laryngoscopy equipment placement, disposable consumable contracts, and clinical evidence partnerships increasingly extend a manufacturer's commercial relationship across a hospital system's entire anesthesia department network rather than a single device purchase, particularly among manufacturers that have successfully bundled video technology and clinical support
Adoption depth varies sharply by end-use vertical. Academic medical centers and large hospital systems navigating fleet-wide video laryngoscopy standardization engage most deeply, given the direct clinical and operational benefits of consistent equipment across their operational scale and multiple anesthesia departments. Smaller community hospitals and ambulatory surgery centers adopt more transactionally, often prioritizing proven device reliability and upfront cost over the deeper fleet relationships that characterize large academic medical center accounts.

A generational shift in buyer profile is underway as anesthesia patient safety officers and clinical quality specialists, increasingly focused on documented outcomes data and standardized protocols, join anesthesiologists and procurement staff in purchasing decisions, a change reshaping which manufacturer capabilities actually win hospital system contracts across institutions of all sizes and clinical specialties.
airway-management-devices-market-end-use-penetration-index-1787297535378

Where Device Manufacturers Should Focus Next

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / VIDEO TECHNOLOGY INVESTMENT

Build video capability before direct laryngoscopy becomes fully obsolete

Clinical guidelines are increasingly recommending video laryngoscopy as a first-line rather than rescue intubation tool, converting video capability from a premium differentiator into a baseline requirement for hospital fleet standardization decisions across anesthesia departments. Manufacturers still concentrated in direct laryngoscopy risk losing hospital contracts to video-enabled competitors already established in this fast-growing segment. Moving now, ahead of the point where video becomes fully commoditized, allows manufacturers to capture premium positioning and durable hospital relationships before competition in this segment intensifies meaningfully further.
02 / CLINICAL EVIDENCE GENERATION

Build outcomes data ahead of broader hospital procurement standardization

Hospital procurement committees increasingly require documented first-pass success and complication reduction data before standardizing on a video laryngoscopy platform, creating genuine first-mover advantage for manufacturers willing to invest in clinical evidence generation partnerships with academic medical centers. Manufacturers building dedicated evidence generation capability now are positioned to capture disproportionate share of hospital fleet standardization decisions before broader competitive entry follows. Waiting until evidence requirements become standard practice and competition intensifies will prove considerably more expensive than establishing early clinical evidence leadership.
03 / COMPREHENSIVE CART BUNDLING

Expand difficult airway cart offerings to capture larger hospital contracts

Hospitals increasingly prefer standardizing entire difficult airway management protocols with a single manufacturer rather than sourcing video laryngoscopy, supraglottic devices, and airway exchange catheters separately across multiple vendor relationships and procurement processes each year. Manufacturers offering comprehensive difficult airway cart bundling capture considerably larger, more durable hospital contracts than single-category competitors can achieve through individual device sales alone. This bundling strategy requires broader product line investment but builds account relationships that single-category competitors cannot easily displace once hospitals have standardized fully.
04 / EMS CHANNEL DEVELOPMENT

Build dedicated prehospital distribution ahead of protocol shifts broadening

Emergency medical services protocols are increasingly favoring supraglottic airway devices for prehospital airway management, creating substantial demand that requires distribution infrastructure and field-specific product validation distinct from hospital-focused sales channels entirely and considerably. Manufacturers building dedicated EMS distribution relationships now are positioned to capture disproportionate share as protocol shifts continue broadening supraglottic adoption across ambulance fleets nationwide. This channel investment requires meaningful sales infrastructure but positions manufacturers ahead of intensifying competition as prehospital care continues evolving toward video-guided and supraglottic-first approaches over time.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Airway Management Devices Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Airway Management Devices Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a regional hospital system generating roughly $1.8 billion in annual revenue (client-reported, unverified by MMA) operating eight hospitals across the midwestern United States. The system relied on a mixed fleet of direct laryngoscopes and video units from multiple manufacturers accumulated over more than a decade and was facing growing clinical quality committee pressure to standardize on video-first intubation protocols following updated anesthesiology society guidelines.
STRATEGIC CHALLENGE
Management needed to decide whether to standardize its entire anesthesia department fleet on a single video laryngoscopy vendor or continue operating a mixed-vendor fleet, given uncertainty about capital cost, staff retraining requirements, and whether any single vendor's imaging quality and clinical evidence sufficiently supported a system-wide standardization decision across all eight facilities.
MMA APPROACH
MMA benchmarked video laryngoscopy imaging quality and clinical evidence across four vendors, modeled total cost of ownership including disposable blade contracts over a five-year horizon, and assessed staff retraining requirements to determine the most cost-efficient standardization pathway for the system's specific case mix, facility configuration, and long-term capital investment plan.
KEY FINDINGS
  1. The client's mixed-vendor fleet carried maintenance and training costs roughly 28% higher than a standardized single-vendor fleet would, driven by inconsistent equipment familiarity and parts inventory complexity across departments.
  2. Two of the four vendors benchmarked offered disposable blade contract terms that reduced total five-year cost of ownership below the client's current mixed-vendor spending despite higher initial equipment placement cost.
  3. Clinical evidence supporting first-pass success rates varied meaningfully across the four vendors, with the two strongest performers showing statistically significant improvement over the client's existing direct laryngoscopy baseline.
  4. Staff retraining requirements were projected to take approximately ten weeks to complete across all eight facilities under a phased rollout rather than a simultaneous system-wide conversion.
CLIENT PROFILE
The client is a regional hospital system generating roughly $1.8 billion in annual revenue (client-reported, unverified by MMA) operating eight hospitals across the midwestern United States. The system relied on a mixed fleet of direct laryngoscopes and video units from multiple manufacturers accumulated over more than a decade and was facing growing clinical quality committee pressure to standardize on video-first intubation protocols following updated anesthesiology society guidelines.
STRATEGIC CHALLENGE
Management needed to decide whether to standardize its entire anesthesia department fleet on a single video laryngoscopy vendor or continue operating a mixed-vendor fleet, given uncertainty about capital cost, staff retraining requirements, and whether any single vendor's imaging quality and clinical evidence sufficiently supported a system-wide standardization decision across all eight facilities.
MMA APPROACH
MMA benchmarked video laryngoscopy imaging quality and clinical evidence across four vendors, modeled total cost of ownership including disposable blade contracts over a five-year horizon, and assessed staff retraining requirements to determine the most cost-efficient standardization pathway for the system's specific case mix, facility configuration, and long-term capital investment plan.
KEY FINDINGS
  1. The client's mixed-vendor fleet carried maintenance and training costs roughly 28% higher than a standardized single-vendor fleet would, driven by inconsistent equipment familiarity and parts inventory complexity across departments.
  2. Two of the four vendors benchmarked offered disposable blade contract terms that reduced total five-year cost of ownership below the client's current mixed-vendor spending despite higher initial equipment placement cost.
  3. Clinical evidence supporting first-pass success rates varied meaningfully across the four vendors, with the two strongest performers showing statistically significant improvement over the client's existing direct laryngoscopy baseline.
  4. Staff retraining requirements were projected to take approximately ten weeks to complete across all eight facilities under a phased rollout rather than a simultaneous system-wide conversion.
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1 to 5): Standardize the two highest-volume facilities on the selected vendor's video laryngoscopy platform under a multi-year disposable blade contract. Phase 2: Phase 2 (Months 6 to 14): Expand standardization across the remaining six facilities using the phased rollout schedule to manage staff retraining requirements. Phase 3: Phase 3 (Months 15 to 24): Complete system-wide standardization and establish centralized clinical outcomes tracking across all eight facility locations.
OUTCOME
The client completed standardization at its two highest-volume facilities within six months of the engagement, financing the equipment placement through the recommended vendor's disposable blade contract structure (client-reported, unverified by MMA). First-pass intubation success rates at converted facilities improved measurably within the first two quarters, and the system's clinical quality committee approved full system-wide rollout under the phased framework.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Airway Management Devices Market?

The global airway management devices market was valued at approximately $3.9 billion in 2025. Growth is being driven by video laryngoscopy guideline adoption and expanding surgical volume.

How large will the Airway Management Devices Market be by 2036?

The market is projected to reach approximately $7.72 billion by 2036, up from $4.15 billion in 2026. This represents nearly a doubling of value over the ten-year forecast window.

What is the CAGR for the Airway Management Devices Market 2026 to 2036?

The market is forecast to grow at a CAGR of 6.4% between 2026 and 2036. Bull and bear scenarios range from roughly 5.1% to 7.5%.

Which segment is growing fastest?

Video laryngoscopes are currently the single fastest-growing segment, expanding at approximately 10.8% annually. This is roughly 1.7 times the overall market's growth rate of 6.4%.

Who are the major companies in the Airway Management Devices Market?

Leading manufacturers in this market include Medtronic, Teleflex, Ambu, Vyaire Medical, and Intersurgical Ltd. Together these five hold roughly 52% of the total global device market.

Which country is growing fastest?

India is currently the single fastest-growing country in this market, expanding at approximately 9.5% annually. This reflects India's rapidly expanding surgical infrastructure and healthcare investment.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Device Type

  • Endotracheal Tubes
  • Supraglottic Airway Devices
  • Video Laryngoscopes
  • Direct Laryngoscopes
  • Tracheostomy Tubes
  • Airway Exchange Catheters and Introducers

By End-Use Setting

  • Hospital Operating Rooms
  • Emergency Departments
  • Intensive Care Units
  • Emergency Medical Services and Prehospital Care

By Commercial Dimension

  • Disposable Device Purchase
  • Video System Equipment Placement
  • Disposable Blade Supply Contracts
  • Comprehensive Cart Standardization Agreements

By Region

  • North America
  • Western Europe
  • East Asia
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, August 2026)
Market Definition
The airway management devices market covers devices used to establish and maintain a patent airway during anesthesia, emergency medicine, and critical care, including endotracheal tubes, supraglottic airway devices, laryngoscopes, tracheostomy tubes, and airway exchange catheters. It excludes mechanical ventilators sold as standalone respiratory support equipment and excludes general anesthesia delivery systems sold independently of airway devices.
Quantitative Units
USD billions (current prices); unit device volume where disclosed
Segmentation Dimensions
By Device Type; By End-Use Setting; By Commercial Dimension; By Region
Regions Covered
North America, Western Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
USA, China, Germany, France, UK, Japan, South Korea, India, Australia, Canada, Brazil, Mexico, Indonesia, Vietnam, Thailand, Malaysia, UAE, Saudi Arabia, South Africa, Nigeria, Turkey, Poland, Netherlands, Italy, Spain, Sweden, Switzerland, Argentina, Colombia, Singapore, and additional markets relevant to this sector
Key Companies Profiled
Medtronic plc, Teleflex Incorporated, Ambu A/S, Vyaire Medical Inc., Intersurgical Ltd., Smiths Medical, GE Healthcare, Verathon Inc, Karl Storz SE and Co KG, Flexicare Medical Ltd, SunMed, Well Lead Medical Co Ltd, Armstrong Medical Ltd, VBM Medizintechnik GmbH, Mercury Medical, Hsiner Co Ltd, Zhejiang Kangbao Medical Devices, Pacific Hospital Supply, Truphatek International, ICU Medical Inc
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-MED-323
Published
August 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Airway Management Devices Market Report (2026 to 2036).

The full report provides a comprehensive assessment of the global airway management devices market, including detailed segmentation by device type, end-use setting, and commercial dimension across all seven world regions. It profiles twenty leading and emerging device manufacturers, benchmarking video technology capability, clinical evidence depth, and distribution channel reach. The analysis includes ten-year forecasts through 2036 under base, bull, and bear scenarios, alongside primary research findings drawn from MMA's survey of 3,800 respondents and 47 expert interviews conducted in the fourth quarter of 2025. A dedicated input cost section examines optical component, medical plastics, and electronics exposure across major manufacturing regions.
Detailed segment-level ten-year forecasts through 2036
Profiles of twenty leading and emerging device manufacturers
Regional analysis spanning all seven world regions
Input cost and supply chain risk assessment
Competitive benchmarking on moats and vulnerabilities
Primary survey and expert interview data appendix

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts